|
An angiodynamics clinical specialist reported an issue during a midline insertion procedure.During the procedure, the access wire was stuck in the patient's arm.The inserter opted to have a doctor remove the wire; it was indicated the wire was pulled back through the access needle, however, when this was performed, a small piece of the wire was retained in the patient's arm.The fragment was not removed as it was embedded in the patient's soft tissue.Surgery had been consulted and the surgeon determined removal was not needed.It was indicated the reported device is available for return to the manufacturer for a device evaluation.
|
|
Returned for evaluation was one guidewire.As received, the guidewire was returned in two pieces and was unraveled.The guidewire component is supplied to angiodynamics by the supplier (b)(4) medical components.Scar004171 and sample were sent to the supplier, (b)(4) medical components for dhr review of supplier lots and root cause/corrective action.Per supplier (b)(4) medical, all inspections results were recorded within specification limits.The product specifications were met with no non-conformities reported for manufacturing and inspection.A general training review was performed.It was verified that all personal was properly trained in all manufacturing process steps and in quality inspection as well.Reference scar004171 response for full investigation details.The complaint description states, "it was indicated the guidewire was pulled back through the access needle".The dfu cautions against this: caution: the guidewire should not be withdrawn through the introducer needle.If the guidewire must be withdrawn while still inside the needle, simultaneously remove both the needle and the wire as a unit to prevent the needle from damaging the guidewire.A definitive root cause for the reported event could not be established, however te most lilkely root cause for guidewire fracture event is end user pulling the guidewire back against the needle; the sharp needle bevel may have cut the wire.Labeling review: direction for use {dfu} contains the following statements: warning: contents supplied sterile using an ethylene oxide (eo) process.Do not use if sterile barrier is damaged.If damage is found, call your navilyst medical representative.Inspect prior to use to verify that no damage has occurred in shipping.For single patient use only.Do not reuse, reprocess or resterilize.Reuse, reprocessing or resterilization may compromise the structural integrity of the device and/or lead to device failure which, in turn, may result in patient injury, illness or death.Operational instructions: 1.Prior to insertion, flush all components with saline or heparinized/saline.2.Gain percutaneous access with the 21 g (0.9 mm) vascular introducer needle.3.Advance the 0.018 inch (0.46 mm) guidewire through the needle.Caution: the guidewire should not be withdrawn through the introducer needle.If the guidewire must be withdrawn while still inside the needle, simultaneously remove both the needle and the wire as a unit to prevent the needle from damaging the guidewire.4.Withdraw the introducer needle, leaving the 0.018 inch (0.46 mm) guidewire in place.5.Advance the coaxial assembly over the 0.018 inch (0.46 mm) guidewire.6.Simultaneously remove the dilator and 0.018 inch (0.46 mm) guidewire, while holding the sheath portion of the assembly in place.7.Advance a 0.035 inch (0.89 mm) or 0.038 inch (0.97 mm) guidewire into the sheath.8.Remove the sheath, leaving the 0.035 inch (0.89 mm) or 0.038 inch (0.97 mm) wire.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
|